BioSpace News Archive

Drug Development

CytRx Corporation Announces Favorable Initial Results from its Ongoing Phase 1b/2 Clinical Trial in Patients with Soft Tissue Sarcomas

October 31, 2011
·
1 min read
Business

22nd Century Group, Inc. Licenses X-22 to Pharmaceutical Subsidiary; New York Times Reports Company Delivers Government Research Cigarettes

October 31, 2011
·
1 min read
Biotech Beach

XYTOS Receives Funding Commitment

October 31, 2011
·
1 min read
Biotech Beach

AVANIR Pharmaceuticals Submits European Marketing Authorization Application for NUEDEXTA

October 31, 2011
·
10 min read
Circadian Technologies Limited Receives FDA IND Approval to Begin Clinical Trials With VGX-100 for the Treatment of Cancer Patients With Solid Tumors

October 31, 2011
·
6 min read
Business

NeurogesX, Inc. Appoints Dr. Stephen J. Peroutka as Executive Vice President and Chief Medical Officer

October 31, 2011
·
1 min read
Drug Development

Telormedix Announces Promising TMX-202 Preclinical Results for Skin Cancer Treatment

October 31, 2011
·
2 min read
Drug Development

Trophos Initiates Phase II Proof of Concept Study for Novel Cardioprotective Compound, TRO40303, in Acute Myocardial Infarction

October 31, 2011
·
6 min read
Business

Antitope Announces Initiation of Antibody Humanization in Collaboration with Kolltan Pharmaceuticals

October 31, 2011
·
2 min read
Bio NC

Furiex Pharmaceuticals, Inc. Study Results to be Presented at the American College of Gastroenterology 2011 Annual Scientific Meeting

October 31, 2011
·
1 min read